Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

TRDATRDA
Showing 8 of 19 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ENTRADA THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 197,136 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $1.5M as of 2026-Q2. The position was decreased (-8.2% shares). TRDA represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$1.5M

Current Shares

197,136

Total Value Change

-$1.5M

Total Shares Change

+11,152

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
197,136
-8.2%
$1.5M0.0%$7.36
0
2026-Q1
Decreased
214,751
-3.0%
$2.7M0.0%$11.85
0
2025-Q4
Increased
221,269
+19.4%
$2.3M0.0%$10.09
31
2025-Q3
Decreased
185,259
-9.1%
$1.1M0.0%$5.84
0
2025-Q2
Increased
203,693
+5.7%
$1.4M0.0%$6.91
27
2025-Q1
Decreased
192,717
-2.2%
$1.7M0.0%$9.56
0
2024-Q4
Increased
197,127
+6.0%
$3.4M0.0%$17.37
28
2024-Q3
Increased
185,984
+14.6%
$3M0.0%$16.45
30

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used